Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521945 | SCV000618181 | uncertain significance | not provided | 2020-04-02 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge; Predicted to result in the in-frame deletion of two amino acid residues and insertion of two incorrect amino acids |
Labcorp Genetics |
RCV002527592 | SCV003268184 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2022-08-02 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 449783). This variant has not been reported in the literature in individuals affected with CNTNAP2-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This variant, c.2136_2137delinsAA, is a complex sequence change that results in the deletion of 2 and insertion of 2 amino acid(s) in the CNTNAP2 protein (p.Asn712_Glu713delinsLysLys). |